Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda

Journal of Infectious Diseases

Volumn 190, Issue 10, 2004, Pages 1869-1879

  Brown, Michael ^a,b   Kizza, Moses ^a   Watera, Christine ^a   Quigley, Maria A ^b   Rowland, Samantha ^a,c   Hughes, Peter ^a   Whitworth, James A G ^a,b   Elliott, Alison M ^a,b  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; PRAZIQUANTEL;

ADULT; ARTICLE; DISEASE COURSE; DRUG EFFECT; FEMALE; HELMINTHIASIS; HOOKWORM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MANSONELLA PERSTANS; MORTALITY; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCREENING; STRONGYLOIDES STERCORALIS; UGANDA; VIRUS LOAD;

ADULT; ALBENDAZOLE; ANCYLOSTOMATOIDEA; ANIMALS; ANTHELMINTICS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HOOKWORM INFECTIONS; HUMANS; MALE; MANSONELLA; MANSONELLIASIS; MORTALITY; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; UGANDA; VIRAL LOAD;

EID: 8444251312     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425042     Document Type: Article

References (33)

1. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature 2001; 410:968-73.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global HIV/AIDS epidemic [UNAIDS/02.26E]. Geneva: UNAIDS, 2002.
3. Bentwich Z, Maartens G, Torten D, Lal AA, Lal RB. Concurrent infections and HIV pathogenesis. AIDS 2000; 14:2071-81.
4. Bundy DA, de Silva NR. Can we deworm this wormy world? Br Med Bull 1998; 54:421-32.
5. Pearlman E, Kazura JW, Hazlett FE Jr, Boom WH. Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol 1993; 151:4857-64.
6. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993; 90:948-52.
7. Sacco R, Hagen M, Sandor M, Weinstock J, Lynch R. Established T(H1) granulomatous responses induced by active mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol 2002; 104:274-81.
8. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996; 173:269-72.
9. Kamal SM, Bianchi L, Al Tawil A, et al. Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis 2001; 184:972-82.
10. Malhotra I, Mungai P, Wamachi A, et al. Helminth- and bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162:6843-8.
11. Borkow G, Leng Q, Weisman Z, et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000; 106:1053-60.
12. Grogan IL, Kremsner PG, Deelder AM, Yazdanbakhsh M. Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis 1998; 177:1433-7.
13. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-42.
14. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999; 274:31868-74.
15. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 1991; 173:589-97.
16. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86:5974-8.
17. Anzala OA, Nagelkerke NJ, Bwayo JJ, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-9.
18. Morgan D, Whitworth J. The natural history of HIV-1 infection in Africa. Nat Med 2001; 7:143-5.
19. French N, Nakiyingi J, Carpenter LM, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355:2106-11.
20. Katz N, Chaves A, Pellegrino N. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
21. Deelder AM, De Jonge N, Boerman OC, et al. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am J Trop Med Hyg 1989; 40:268-72.
22. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 1997; 56:515-21.
23. Brown M, Bukusuba J, Hughes P, et al. Screening for intestinal helminth infestation in a semi-urban cohort of HIV-infected people in Uganda: a combination of techniques may enhance diagnostic yield in the absence of multiple stool samples. Trop Doct 2003; 33:72-6.
24. Melrose WD, Turner PF, Pisters P, Turner B. An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg 2000; 94:176.
25. + T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg 2003; 97: 103-8.
26. Kongs A, Marks G, Verle P, van der Stuyft P. The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections. Trop Med Int Health 2001; 6:163-9.
27. Utzinger J, Booth M, N'Goran EK, Muller I, Tanner M, Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 2001; 122:537-44.
28. Viney M. How do host immune responses affect nematode infections? Trends Parasitol 2002; 18:63-6.
29. Kalinkovich A, Weisman Z, Greenberg Z, et al. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 1998; 114:414-21.
30. Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exp Immunol 1996; 103:239-43.
31. Pollack S, Fuad B, Etzioni A. CD4 T-lymphocytopenia without opportunistic infections in HIV-seronegative Ethiopian immigrants to Israel. Lancet 1993; 342:50.
32. Hazenberg MD, Otto SA, Wit FW, Lange JM, Hamann D, Miedema F. Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss. AIDS 2002; 16:1287-9.
33. Andrieu JM, Lu W, Levy R. Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis 1995; 171:523-30.